134 related articles for article (PubMed ID: 393519)
1. Hypotensive action and side-effects of flutonidin in normal subjects. A double-blind controlled trial.
Sala P; Chierichetti SM; Ferrari P
Eur J Clin Pharmacol; 1979; 16(6):375-9. PubMed ID: 393519
[TBL] [Abstract][Full Text] [Related]
2. An alternative method of assessing changes in salivary flow: comparison of the effects of clonidine and tiamenidine (HOE 440).
Findlay D; Lawrence JR
Eur J Clin Pharmacol; 1978 Dec; 14(4):231-5. PubMed ID: 729618
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.
Macphee GJ; Howie CA; Elliott HL; Reid JL
Br J Clin Pharmacol; 1992 Mar; 33(3):261-7. PubMed ID: 1576046
[TBL] [Abstract][Full Text] [Related]
4. Double-blind comparison of the hypotensive, sedative and salivary flow effects of lofexidine and clonidine in normal subjects.
Dollery CT; Reid JL
Arzneimittelforschung; 1982; 32(8a):984-7. PubMed ID: 6890374
[TBL] [Abstract][Full Text] [Related]
5. [New antihypertensive agent of the imidazoline series: 5-fluoro-methyl-imidazolidinylidene-benzamine-monohydrochloride (flutonidin)].
Brunner H; Djawan S; Dorda W; Penner E; Grabner G
Arzneimittelforschung; 1977; 27(8):1599-604. PubMed ID: 334188
[TBL] [Abstract][Full Text] [Related]
6. The central hypotensive effect of clonidine. Studies in tetraplegic subjects.
Reid JL; Wing LM; Mathias CJ; Frankel HL; Neill E
Clin Pharmacol Ther; 1977 Apr; 21(4):375-81. PubMed ID: 321174
[TBL] [Abstract][Full Text] [Related]
7. Central nervous system depressant actions of clonidine and UK-14,304: partial dissociation of EEG and behavioural effects.
Ashton H; Rawlins MD
Br J Clin Pharmacol; 1978 Feb; 5(2):135-40. PubMed ID: 619947
[No Abstract] [Full Text] [Related]
8. General pharmacology of the novel centrally acting antihypertensive agent moxonidine.
Armah BI; Hofferber E; Stenzel W
Arzneimittelforschung; 1988 Oct; 38(10):1426-34. PubMed ID: 3196383
[TBL] [Abstract][Full Text] [Related]
9. A comparative trial of timolol and flutonidin as antihypertensive agents.
Salvadeo A; Segagni S; Villa G; Galli F; Piazza W; Bovio G
Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):78-84. PubMed ID: 7037661
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the interaction between mianserin and centrally-acting antihypertensive drugs.
Elliott HL; Whiting B; Reid JL
Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):323S-328S. PubMed ID: 6824563
[TBL] [Abstract][Full Text] [Related]
11. [Long-term treatment with a new antihypertensive drug: flutonidin].
Nicrosini F; Pasotti C
Minerva Med; 1983 May; 74(21):1297-300. PubMed ID: 6406947
[TBL] [Abstract][Full Text] [Related]
12. Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males.
Weerasuriya K; Shaw E; Turner P
Eur J Clin Pharmacol; 1984; 27(3):281-6. PubMed ID: 6150856
[TBL] [Abstract][Full Text] [Related]
13. Effects of rilmenidine and clonidine on the electroencephalogram, saccadic eye movements, and psychomotor function.
Harron DW; Hasson B; Regan M; McClelland RJ; King DJ
J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S48-54. PubMed ID: 8642806
[TBL] [Abstract][Full Text] [Related]
14. Lack of interaction between the tetracyclic antidepressant maprotiline and the centrally acting antihypertensive drug clonidine.
Gundert-Remy U; Amann E; Hildebrandt R; Weber E
Eur J Clin Pharmacol; 1983; 25(5):595-9. PubMed ID: 6662159
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and concentration-effect relationships of clonidine in essential hypertension.
Wing LM; Reid JL; Davies DS; Neill EA; Tippett P; Dollery CT
Eur J Clin Pharmacol; 1977 Dec; 12(6):463-9. PubMed ID: 598422
[TBL] [Abstract][Full Text] [Related]
16. Comparison between the effects of ST 600 and clonidine.
Kho TL; Schalekamp MA; Zaal GA; Wester A; Birkenhäger WH
Arch Int Pharmacodyn Ther; 1975 Sep; 217(1):162-9. PubMed ID: 1190909
[TBL] [Abstract][Full Text] [Related]
17. Sedative and cardiovascular effects of medetomidine, a novel selective alpha 2-adrenoceptor agonist, in healthy volunteers.
Scheinin M; Kallio A; Koulu M; Viikari J; Scheinin H
Br J Clin Pharmacol; 1987 Oct; 24(4):443-51. PubMed ID: 2891369
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology and pharmacokinetics of clonidine.
Dollery CT; Davies DS; Draffan GH; Dargie HJ; Dean CR; Reid JL; Clare RA; Murray S
Clin Pharmacol Ther; 1976 Jan; 19(1):11-7. PubMed ID: 1245090
[TBL] [Abstract][Full Text] [Related]
19. Sedative and cardiovascular effects of clonidine and nitrazepam.
Hossmann V; Maling TJ; Hamilton CA; Reid JL; Dollery CT
Clin Pharmacol Ther; 1980 Aug; 28(2):167-76. PubMed ID: 7398184
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of flutonidin after acute oral administration.
Mazzola C; Guffanti E; Ferrario N
Farmaco Prat; 1981 May; 36(5):262-70. PubMed ID: 7238849
[No Abstract] [Full Text] [Related]
[Next] [New Search]
